Electronic letters to boost heart health awareness
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests whether simple electronic letters can motivate people with heart disease to better manage their health, especially their cholesterol levels. If you have high Lp(a) — a type of cholesterol linked to heart risk — you may also get a special letter about that.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must live in Denmark and be between 18 and 85 years old.
- You must have been diagnosed with ischemic heart disease (a heart condition that reduces blood flow to the heart) more than 6 months ago.
- Your latest LDL cholesterol ('bad cholesterol') test must be above 1.4 mmol/L (from a test in the last 3 years).
- You must not live in a nursing home.
- You must have access to Digital Post (Danish electronic mail system).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a heart CT scan to look for early signs of heart disease in first-degree relatives of people with high or low Lp(a). It aims to find hidden risks before symptoms start.
This trial tests a new method called LILAC to help people learn about and manage high levels of lipoprotein(a), a type of fat in the blood. It is for anyone 16 or older who attends educational events or is part of a health group.
This trial tests ways to help doctors check for high Lp(a), a risk factor for heart disease, in patients who need it. The study looks at whether special strategies increase testing rates in cardiology centers that currently test less than 15% of eligible patients.
This study tests an educational program to help people understand and lower their LDL ('bad') cholesterol after a heart-related event. It aims to improve awareness and encourage the use of cholesterol-lowering treatments.
This study tests whether an educational program can help people with high cholesterol and heart disease get their LDL cholesterol levels lower. It involves watching online videos and working with your doctor to adjust treatments.
This study tests an oral medication called HRS-5346 to see if it can lower a type of fat in the blood called lipoprotein(a), which is linked to heart disease. If you have high Lp(a) and are at risk for heart problems, this trial may help reduce that risk.
Hear when a new Ischemic Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.